Moore AP - Search Results

1

A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke.

Pittock SJ, Moore AP, Hardiman O, Ehler E, Kovac M, Bojakowski J, Al Khawaja I, Brozman M, Kanovský P, Skorometz A, Slawek J, Reichel G, Stenner A, Timerbaeva S, Stelmasiak Z, Zifko UA, Bhakta B, Coxon E. Pittock SJ, et al. Among authors: moore ap. Cerebrovasc Dis. 2003;15(4):289-300. doi: 10.1159/000069495. Cerebrovasc Dis. 2003. PMID: 12686794 Clinical Trial.

2

A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke.

Bakheit AM, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, Coxon L. Bakheit AM, et al. Among authors: moore ap. Eur J Neurol. 2001 Nov;8(6):559-65. doi: 10.1046/j.1468-1331.2001.00277.x. Eur J Neurol. 2001. PMID: 11784339 Clinical Trial.

3

Botulinum toxin A (BoNT-A) for spasticity in adults. What is the evidence?

Moore AP. Moore AP. Eur J Neurol. 2002 May;9 Suppl 1:42-7; dicussion 53-61. doi: 10.1046/j.1468-1331.2002.0090s1042.x. Eur J Neurol. 2002. PMID: 11918649 Review.

4

The medical management of masseteric hypertrophy with botulinum toxin type A.

Moore AP, Wood GD. Moore AP, et al. Br J Oral Maxillofac Surg. 1994 Feb;32(1):26-8. doi: 10.1016/0266-4356(94)90168-6. Br J Oral Maxillofac Surg. 1994. PMID: 8136334 Clinical Trial.

5

Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy.

Moore AP, Ade-Hall RA, Smith CT, Rosenbloom L, Walsh HP, Mohamed K, Williamson PR. Moore AP, et al. Neurology. 2008 Jul 8;71(2):122-8. doi: 10.1212/01.wnl.0000316801.74683.c0. Neurology. 2008. PMID: 18606966 Clinical Trial.

6

A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury.

Smith SJ, Ellis E, White S, Moore AP. Smith SJ, et al. Among authors: moore ap. Clin Rehabil. 2000 Feb;14(1):5-13. doi: 10.1191/026921500666642221. Clin Rehabil. 2000. PMID: 10688339 Clinical Trial.

7

Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy.

Ade-Hall RA, Moore AP. Ade-Hall RA, et al. Among authors: moore ap. Cochrane Database Syst Rev. 2000;(2):CD001408. doi: 10.1002/14651858.CD001408. Cochrane Database Syst Rev. 2000. PMID: 10796784 Review.

8

A double blind trial of botulinum toxin "A" in torticollis, with one year follow up.

Moore AP, Blumhardt LD. Moore AP, et al. J Neurol Neurosurg Psychiatry. 1991 Sep;54(9):813-6. doi: 10.1136/jnnp.54.9.813. J Neurol Neurosurg Psychiatry. 1991. PMID: 1955900 Free PMC article. Clinical Trial.

9

Botulinum toxin type B for cervical dystonia.

Marques RE, Duarte GS, Rodrigues FB, Castelão M, Ferreira J, Sampaio C, Moore AP, Costa J. Marques RE, et al. Among authors: moore ap. Cochrane Database Syst Rev. 2016 May 13;2016(5):CD004315. doi: 10.1002/14651858.CD004315.pub3. Cochrane Database Syst Rev. 2016. PMID: 27176573 Free PMC article. Review.

10

Botulinum toxin type A therapy for cervical dystonia.

Castelão M, Marques RE, Duarte GS, Rodrigues FB, Ferreira J, Sampaio C, Moore AP, Costa J. Castelão M, et al. Among authors: moore ap. Cochrane Database Syst Rev. 2017 Dec 12;12(12):CD003633. doi: 10.1002/14651858.CD003633.pub3. Cochrane Database Syst Rev. 2017. PMID: 29230798 Free PMC article. Updated. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page